{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:16:07Z","timestamp":1790838967693,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cmpb.2019.104989","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:27:34Z","timestamp":1563881254000},"page":"104989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease"],"prefix":"10.1016","volume":"179","author":[{"given":"B.","family":"Taverna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Galvanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2019.104989_bib0001","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans. Automat. Contr."},{"key":"10.1016\/j.cmpb.2019.104989_bib0002","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01062273","article-title":"Experimental design and efficient parameter estimation in population pharmacokinetics","volume":"18","author":"Al-Banna","year":"1990","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.cmpb.2019.104989_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0959-1524(01)00020-8","article-title":"Designing robust optimal dynamic experiments","volume":"12","author":"Asprey","year":"2002","journal-title":"J. Process Control"},{"key":"10.1016\/j.cmpb.2019.104989_bib0004","series-title":"Nonlinear Parameter Estimation","author":"Bard","year":"1974"},{"key":"10.1016\/j.cmpb.2019.104989_bib0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/00401706.1960.10489912","article-title":"Some new 3 level designs for the study of quantitative variables","volume":"2","author":"Box","year":"1960","journal-title":"Technometrics"},{"key":"10.1016\/j.cmpb.2019.104989_bib0006","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0031-1281029","article-title":"Assessment of von willebrand factor propeptide improves the diagnosis of von Willebrand disease","volume":"37","author":"Casonato","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.cmpb.2019.104989_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lab.2005.10.002","article-title":"Identifying type Vicenza von Willebrand disease","volume":"147","author":"Casonato","year":"2006","journal-title":"J Lab Clin. Med."},{"key":"10.1016\/j.cmpb.2019.104989_bib0008","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/cjce.22964","article-title":"A model-based protocol for the diagnosis of von Willebrand disease","volume":"96","author":"Castaldello","year":"2018","journal-title":"Can. J. Chem. Eng."},{"key":"10.1016\/j.cmpb.2019.104989_bib0009","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ndt\/gfg065","article-title":"A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas\u2013kidney transplant recipients","volume":"18","author":"Cremers","year":"2003","journal-title":"Nephr. Dial. Transplant"},{"key":"10.1016\/j.cmpb.2019.104989_bib0010","series-title":"Optimal Design For Nonlinear Response Models","author":"Fedorov","year":"2014"},{"key":"10.1016\/j.cmpb.2019.104989_bib0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1160\/TH17-05-0375","article-title":"A mechanistic model to quantify von Willebrand factor Release, Survival and proteolysis in patients with von Willebrand disease","volume":"118","author":"Ferrari","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.cmpb.2019.104989_bib0012","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10928-013-9321-5","article-title":"A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models","volume":"40","author":"Galvanin","year":"2013","journal-title":"J. Pharmacokinet. Pharmacodyn"},{"key":"10.1016\/j.cmpb.2019.104989_bib0013","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/aic.14373","article-title":"A model-based approach to the automatic diagnosis of von Willebrand disease","volume":"60","author":"Galvanin","year":"2014","journal-title":"AIChE J."},{"key":"10.1016\/j.cmpb.2019.104989_bib0014","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1538-7836.2009.03433.x","article-title":"The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission","volume":"7","author":"Groot","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cmpb.2019.104989_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/00401706.2014.995833","article-title":"A decomposition strategy for the variational inference of complex systems","volume":"58","author":"La\u00ednez-Aguirre","year":"2016","journal-title":"Technometrics"},{"key":"10.1016\/j.cmpb.2019.104989_bib0016","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","article-title":"Clearance mechanisms of von Willebrand factor and factor VIII","volume":"5","author":"Lenting","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cmpb.2019.104989_bib0017","first-page":"57","article-title":"Von Willebrand disease-phenotype versus genotype: deficiency versus disease","volume":"87","author":"Lillicrap","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cmpb.2019.104989_bib0018","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x","article-title":"Pharmacokinetics of von willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis","volume":"94","author":"Menache","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cmpb.2019.104989_bib0019","unstructured":"OriginLab Corporation, Origin 8 User Guide, Northampton, 2007."},{"key":"10.1016\/j.cmpb.2019.104989_bib0020","series-title":"gPROMS Advanced User Guide","year":"2004"},{"key":"10.1016\/j.cmpb.2019.104989_bib0021","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cmpb.2019.104989_bib0022","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0049-3848(92)90097-T","article-title":"Intraplatelet von Willebrand factor and AB0 blood group","volume":"68","author":"Sweeney","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cmpb.2019.104989_bib0023","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/AAC.47.9.2888-2891.2003","article-title":"Optimal sampling schedule design for populations of patients","volume":"47","author":"Tam","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cmpb.2019.104989_bib0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0049-3848(97)00104-7","article-title":"New families with von Willebrand disease type 2M (Vicenza)","volume":"87","author":"Zieger","year":"1997","journal-title":"Thromb. Res."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719302883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260719302883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T03:50:13Z","timestamp":1759204213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260719302883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"alternative-id":["S0169260719302883"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2019.104989","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A framework for the optimal design of a minimum set of clinical trials to characterize von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2019.104989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104989"}}